[GLP-1 receptor agonists: an effective wide-spectrum therapeutic approach in the treatment of type 2 diabetes mellitus]

Med Clin (Barc). 2014 Sep:143 Suppl 2:1. doi: 10.1016/S0025-7753(14)70100-9. Epub 2014 Oct 15.

[Article in Spanish]

Authors

Javier Salvador¹, Sonia Gaztambide²

Affiliations

¹ Servicio de Endocrinología y Nutrición, Clínica Universidad de Navarra, Pamplona, España. Electronic address: jsalvador@unav.es.
² Servicio de Endocrinología y Nutrición, Hospital Universitario de Cruces, Bilbao, España.

PMID: 25437457
DOI: 10.1016/S0025-7753(14)70100-9

No abstract available

Publication types

Introductory Journal Article

MeSH terms

Diabetes Mellitus, Type 2 / drug therapy*
Glucagon-Like Peptide-1 Receptor
Humans
Hypoglycemic Agents / pharmacology
Hypoglycemic Agents / therapeutic use*
Receptors, Glucagon / agonists*
Receptors, Glucagon / physiology

Substances

GLP1R protein, human
Glucagon-Like Peptide-1 Receptor
Hypoglycemic Agents
Receptors, Glucagon